Vanderbilt Ingram Cancer Center — Nashville, Tennessee

Vanderbilt Ingram Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37232.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Vanderbilt Ingram Cancer Center has participated in 57 clinical trials with 15 currently active.

Therapeutic areas: Advanced Pancreatic Cancer, Multiple Myeloma, Diffuse Large B Cell Lymphoma.

Sponsors: OSI Pharmaceuticals, Janssen Research & Development, LLC, Idera Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt Ingram Cancer Center?

Vanderbilt Ingram Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt Ingram Cancer Center conducted?

Vanderbilt Ingram Cancer Center has 57 clinical trials on record, with 15 currently active. Their work covers Advanced Pancreatic Cancer, Multiple Myeloma, Diffuse Large B Cell Lymphoma.

Is Vanderbilt Ingram Cancer Center accredited by Crixeo Health?

Vanderbilt Ingram Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt Ingram Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.